We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mesoblast Receives FDA Clearance for Phase 2 Trial of MPCs in Active RA Patients

News   May 16, 2013

 
Mesoblast Receives FDA Clearance for Phase 2 Trial of MPCs in Active RA Patients
 
 
 

RELATED ARTICLES

Functioning 3D Human Neural Networks Developed From Stem Cells

News

This 3D neuro-model could help uncover early stage biomarkers of disease, in turn supporting earlier diagnosis and improving understanding of disease progression.

READ MORE

Evidence for Direct Influence of Autonomic Neurotransmitters on Stem Cell Proliferation

News

The autonomic nervous system may directly influence intestinal epithelial stem cell proliferation.

READ MORE

Proactive Approach Protects Population From HIV

News

A preventative approach to HIV drastically reduced the number of HIV diagnoses in New South Wales, Australia.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE